Primary Record
Retosiban
Note: Only for scientific research or as raw materials for production.
- In stock
- 7,316 g
- Purity
- 98.8 %
- CAS
- 820957-38-8
Compound Identifiers & Properties
- CAS
- 820957-38-8
- PubChem CID
- 11340891
- SMILES
- CC[C@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](C2=COC(=N2)C)C(=O)N3CCOCC3)C4CC5=CC=CC=C5C4
- Canonical SMILES
- CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(C)n1
Names & Synonyms
- Retosiban
- retosibanum
- Retosiban [USAN]
- 820957-38-8
- Retosiban [USAN:INN]
- Retosiban (USAN)
- GIE06H28OX
- GSK221149A
- UNII-GIE06H28OX
- GSK-221149A
- RETOSIBAN [INN]
- GSK221149
- RefChem:879490
- D04QZI
- GSK 221149A
- CHEMBL429736
- SCHEMBL230301
- DTXSID00231559
- GTPL8403
- orb1706726
- GSK-221149
- SCHEMBL29376892
- DTXCID80154050
- CHEBI:188651
- PLVGDGRBPMVYPB-FDUHJNRSSA-N
- C27H34N4O5
- ZINC6718496
- BDBM50372608
- EX-A12369
- MFCD19443707
- AKOS040742542
- GSK-221,149-A
- DB11818
- CID11340891
- CID 11340891
- DA-67173
- HY-14778
- MS-29186
- CS-0003555
- NS00070346
- GSK 221149; GSK 221149A
- J3.542.064I
- A13106
- D08986
- G14036
- A857525
- (3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl]piperazine-2,5-dione
- Q7316883
- (3R,6R)-6-((2S)-Butan-2-yl)-3-(2,3-dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl- 1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl)piperazine-2,5-dione
- (3R,6R)-6-[(2S)-Butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl]piperazine-2,5-dione
- Morpholine, 4-((2R)-((3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-((1S)-1- methylpropyl)-2,5-dioxo-1-piperazinyl)(2-methyl-4-oxazolyl)acetyl)-
- (3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione
- (3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl-4-oxazolyl)-2-(4-morpholinyl)-2-oxoethyl)-6-((1S)-1-methylpropyl)-2,5-piperazinedione
- (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
- (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2.5-piperazinedione
- (3R,6R)-3-indan-2-yl-1-[(1R)-1-(2-methyloxazol-4-yl)-2-morpholino-2-oxo-ethyl]-6-[(1S)-1-methylpropyl]piperazine-2,5-dione
- (3R,6R)-6-((2S)-BUTAN-2-YL)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-((1R)-1-(2-METHYL-1,3-OXAZOL-4-YL)-2-(MORPHOLIN-4-YL)-2-OXOETHYL)PIPERAZINE-2,5-DIONE
- (3R,6R)-6-((2S)-butan-2-yl)-3-(2,3-dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl)piperazine-2,5-dione
- 1-[(R)-1-(2-Methyloxazole-4-yl)-2-oxo-2-morpholinoethyl]-3beta-(indan-2alpha-yl)-6beta-[(S)-sec-butyl]piperazine-2,5-dione
- 2,5-Piperazinedione, 3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-4-oxazolyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-, (3R,6R)-
- MORPHOLINE, 4-((2R)-2-((3R,6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-6-((1S)-1-METHYLPROPYL)-2,5-DIOXO-1-PIPERAZINYL)-2-(2-METHYL-4-OXAZOLYL)ACETYL)-